# Proton Pump Inhibitors and Risk of Community-acquired Pneumonia

> **NCT02555852** · — · COMPLETED · sponsor: **Canadian Network for Observational Drug Effect Studies, CNODES** · enrollment: 4238504 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease (GERD)
- Community-acquired Pneumonia

## Interventions

- **DRUG:** esomeprazole
- **DRUG:** omeprazole
- **DRUG:** pantoprazole
- **DRUG:** lansoprazole
- **DRUG:** rabeprazole
- **DRUG:** cimetidine
- **DRUG:** ranitidine
- **DRUG:** famotidine
- **DRUG:** nizatidine
- **DRUG:** niperotidine
- **DRUG:** roxatidine
- **DRUG:** ranitidine bismuth citrate
- **DRUG:** lafutidine
- **DRUG:** cimetidine combinations
- **DRUG:** famotidine combinations

## Key facts

- **NCT ID:** NCT02555852
- **Lead sponsor:** Canadian Network for Observational Drug Effect Studies, CNODES
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 4238504 (ACTUAL)
- **Last updated:** 2015-09-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02555852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02555852, "Proton Pump Inhibitors and Risk of Community-acquired Pneumonia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02555852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*